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Cystic fibrosis (CF) is a hereditary disease due to mutations in the CFTR gene and causes mortality in 
humans mainly due to respiratory infections caused by Pseudomonas aeruginosa. In a previous work we 
used phage therapy, which is a treatment with a mix of phages, to actively counteract acute P. aeruginosa 
infections in mice and Galleria mellonella larvae. In this work we apply phage therapy to the treatment of 
P. aeruginosa PAO1 infections in a CF zebrafish model. The structure of the CFTR channel is evolutionary 
conserved between fish and mammals and cftr-loss-of-function zebrafish embryos show a phenotype 
that recapitulates the human disease, in particular with destruction of the pancreas. We show that phage 
therapy is able to decrease lethality, bacterial burden, and the pro-inflammatory response caused by PAO1 
infection. In addition, phage administration relieves the constitutive inflammatory state of CF embryos. 
To our knowledge, this is the first time that phage therapy is used to cure P. aeruginosa infections in a 
CF animal model. We also find that the curative effect against PAO1 infections is improved by combining 
phages and antibiotic treatments, opening a useful therapeutic approach that could reduce antibiotic 
doses and time of administration.
One of the most serious health emergencies in the last decades is the reappearance of bacterial infections1,2. This 
serious fallout is a consequence of the rapid spread of resistance towards currently in use antibiotics among path-
ogenic bacteria together with the difficulty in discovering new effective antibiotics. In addition, the appearance 
and diffusion of multidrug resistant (MDR) isolates make the situation even worse3. Thus, alternative therapies 
are urgently needed and bacteriophages (phages), the natural enemies of bacteria, can be a possible solution. 
Compared to antibiotics, phages have several advantages: first, they infect only very specific bacterial hosts avoid-
ing damage to healthy commensal microbiota4; second, phages are self-controlling their dose: they multiply when 
and where the target bacterial host strains are present, increasing their number at the infection site only as long as 
the target bacteria are eliminated5; lastly, phages are able to kill also MDR bacteria6.
The idea of using phages against bacteria is not new: the first attempts were made almost a century ago7. 
However, due to the lack of knowledge of the phage reproductive cycle, the therapy alternated successes and fail-
ures and, with the advent of antibiotics, phages were abandoned in the Western world unless for compassionate 
treatments8,9, although they are currently in use in Eastern world. Nowadays, many details of the reproduction of 
phages have been thoroughly clarified, which facilitate their use in therapy and guidelines have been suggested for 
preparation and use of phages as therapeutic agents10.
In the last years, an increasing number of reports on the effectiveness of phage therapy in controlling bacte-
rial infections have been provided, ranging from Klebsiella pneumoniae pulmonary infections11, Pseudomonas 
aeruginosa keratitis12, or P. aeruginosa infected mice4,13,14. In a recent report15, we isolated and characterized 
virulent phages capable of infecting P. aeruginosa, and sequenced their genomes to exclude the presence of any 
gene potentially harmful in therapy. Different phages were mixed in a cocktail and used to treat P. aeruginosa 
acute infections in mouse and Galleria mellonella larvae. Phage therapy was successful in both model systems. 
Moreover, we found that the efficacy of the therapy was improved using a phage cocktail compared to the use 
1Dipartimento di Biotecnologie Mediche e Medicina traslazionale, Università degli Studi di Milano – LitA, via fratelli 
Cervi 93, 20090, Segrate, MI, Italy. 2Istituto FIRC di Oncologia Molecolare – IFOM, Via Adamello 16, 20139, Milano, 
Italy. 3Dipartimento di Bioscienze, Università degli Studi di Milano, Via Celoria 26, 20133, Milano, Italy. 4Dipartimento 
di Biotecnologie e Scienze della Vita, Università degli Studi dell’Insubria, Via J.H. Dunant 3, Varese, Italy. Marco 
Cafora and Gianluca Deflorian contributed equally. Correspondence and requests for materials should be addressed 
to A.P. (email: anna.pistocchi@unimi.it)
Received: 8 August 2018
Accepted: 11 December 2018
Published: xx xx xxxx
opeN
www.nature.com/scientificreports/
2Scientific RepoRts |          (2019) 9:1527  | https://doi.org/10.1038/s41598-018-37636-x
of a single phage15,16, a likely consequence of the enlargement of the host range and of the reduced frequency of 
bacteria resistant to phages, as reported by Chadha et al.17.
P. aeruginosa infections are particularly serious in patients affected by cystic fibrosis (CF) being one of the 
major causes of mortality and morbidity18. Cystic fibrosis is a recessive genetic disease caused by mutation of the 
gene which encodes the cystic fibrosis transmembrane regulator (CFTR), a chloride ion channel19. Due to wide-
spread CFTR protein channel distribution, CF affects multiple organs including the lung, gastrointestinal tract, 
liver, male reproductive tract and pancreas. One of the major complications in CF patients is chronic infection 
of the airways, principally caused by P. aeruginosa, and as a consequence, CF patients are subject to frequent 
antibiotic treatments to control the infections. The positive outcome of acute P. aeruginosa infections obtained 
by phage therapy encouraged us to further investigate its use in a CF background, and we chose zebrafish (Danio 
rerio) as a model system to validate it. Indeed, zebrafish represents a good model for CF as the zebrafish Cftr 
channel has a similar structure to the human CFTR20 and embryos with cftr knock-down present a specific sensi-
tivity to infection with PAO1, in line with the susceptibility of CF patients to this bacterium21,22. Indeed, although 
fish do not have lung, the mainly affected organ by P. aeruginosa infection in CF patients, they have mucins, the 
proteins overexpressed in the lungs of CF patients. Zebrafish mucins are highly homologues to human mucins 
in terms of genomic and protein domain organization23. This observation, together with evidences of a develop-
ment of P. aeruginosa microcolonies, the precursors of biofilm, in zebrafish24, make zebrafish a good model to 
study P. aeruginosa infection in all organs but lungs. Moreover, deregulation of cftr function in zebrafish causes 
a phenotype that mirrors other defects present in the human disease such as severe pancreatic dysfunction25,26, 
not observed in CF mouse model27 and hematopoietic defects that might explain the anaemia presented by CF 
patients28. Zebrafish possesses an additional advantage as it lacks an adaptive immune response for the first 4–6 
weeks of life representing an ideal model for studying innate immunity29, which is the critical defence mecha-
nism in human lung infections30. Indeed, it has been demonstrated that pathogen recognition and inflammation 
response through the release of cytokines occurs in similar manners in zebrafish and humans31.
In this work, using cftr-loss-of-function zebrafish embryos (CF embryos), we demonstrate that phage therapy 
is effective against P. aeruginosa infections. Moreover, we show that by combining phages and antibiotic treat-
ments, the curative effect is improved suggesting that the administration of phages together with antibiotics could 
reduce antibiotic doses and time of administration.
Results
Pseudomonas aeruginosa PAO1 infection of zebrafish embryos. PAO1 infection was performed 
in zebrafish embryos at 48 hours post infection (hpi) by microinjecting into the duct of Cuvier approximately 30 
colony forming units (cfu)/embryo, as previously described32. Bacterial dispersion within the embryo occurred 
immediately, as evaluated by disappearance of the dye tracer co-injected with the bacterial suspension. The dis-
tribution of fluorescent bacteria within the embryos was followed by microscopy: as reported in Fig. 1a, at 20 hpi 
bacteria could be visualized in different organs of the embryos, indicating that bacterial infection can spread in 
the whole embryo. Moreover, we verified that PAO1 infection was recognized by host immune system. By micro-
injecting the tol2(mpeg1:mCherry) construct that labels the macrophages, we observed their migration towards 
GFP positive PAO1 and that bacteria were engulfed by macrophages (Fig. 1b).
Generation of a zebrafish CF model. To obtain a CF background in which validating the efficacy of phage 
therapy against PAO1 infections, we generated cftr-loss-of-function zebrafish embryos (CF embryos), by inject-
ing the cftr morpholinos previously used and characterized21. The embryos exhibited the phenotypes already 
described21,25. Indeed, by in situ hybridization analyses, we demonstrated that the position of the internal organs such 
as heart, liver and pancreas was impaired in CF embryos at 48 hours post fertilization (hpf). The heart, visualised by 
cardiac myosin light chain 2 (cmlc2) probe, normally is left-looping. Indeed, the percentages of WT embryos were: 
90% left-looping, 10% middle and 0% right-looping heart (N = 50). At the contrary, in CF embryos the percentages 
were: 51% left-looping, 37% middle and 12% right-looping heart, indicating a defect in heart looping (Fig. 2a). 
Figure 1. Infection of zebrafish embryos with PAO1. (a) PAO1-GFP injected bacteria were visualized in 
different districts of the embryo at 20 hpi. Cns: central nervous system. Scale bar indicates 100 μm. (b) Injection 
of the tol2(mpeg1:mcherry) plasmid allowed the visualization of red macrophages migrating towards green 
PAO-GFP bacteria. Starting from 10 hpi, different images of the same region of the trunk were taken every 
15 minutes. Scale bar indicates 20 μm.
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Also the normally left-position of the liver, visualised by prox1a probe, was impaired in the CF: 96% left-liver 
in WT compared to 57% left-liver in CF embryos at 48 hpf (N = 50) (Fig. 2b). Moreover, the CF embryos pre-
sented a delayed immune response following bacterial infection in comparison to the WT, as shown by signifi-
cantly reduced TNF-α and IL-β activation at 8 hpi (Fig. 2c). To ascertain that PAO1 was able to form the biofilm, 
typical of CF lung colonization, we injected about 100 cfu of PAO1 in the hindbrain ventricle of 24 hpf zebrafish 
embryos, as reported by Rocker and colleagues24, and observed bacterial colonization by time laps analyses at 
confocal microscopy (Suppl. Video S1). At 18 hpi several microcolonies were visualized in the embryos, indicating 
that PAO1 has started to form the biofilm. Interestingly, the area of microcolonies formed in CF embryos was 
higher than in WT embryos (Fig. 1d).
Validation of the phage therapy against PAO1 infection in WT and CF zebrafish embryos. PAO1 
infection on WT and CF zebrafish embryos was performed as described above with injection in the duct of 
Cuvier at 48 hpf of approximately 30 cfu/embryo, a dose that caused 50% lethality after 20 hpi (Suppl. Fig. S1). For 
each treatment, 35–40 embryos were injected and the experiment was repeated at least fourfold. To compare the 
susceptibility to PAO1 infections of WT and CF, we infected both types of embryos and analysed the lethality at 
20 hpi. As expected, the CF embryos were more susceptible to PAO1 infection as they exhibited a highly signifi-
cant increased lethality in comparison to WT (83 ± 9% vs 66 ± 6%, respectively) at 20 hpi (Fig. 3a).
Four phages of our collection, able to infect PAO1 strain, were chosen to be mixed in a cocktail. Description 
of the phages is reported in Table S1. We preliminarily assess the activity of the phage cocktail in the treatment of 
PAO1 infection in G. mellonella larvae. We observed that lethality of PAO1 infected larvae at 20 hpi was signifi-
cantly reduced from 66 ± 3% to 46 ± 6% when treated with the phage cocktail (Suppl. Fig. S2), thus confirming 
that the phage cocktail was active against PAO1 acute infections.
Then, to test the efficacy of phage therapy in zebrafish, we injected the same phage cocktail in PAO1-infected 
WT embryos; an inoculum of 2 nl of the phage cocktail, containing approximately 300–500 plaque forming units 
(pfu)/embryo, was injected in the yolk sac of PAO1-infected embryos (PAO1 + φ) at two different time points: 
about 30 min (early) and 7 hours (late) after bacterial injection. A highly significant reduction in terms of embryo 
lethality was observed with either injection time: lethality was reduced from 70 ± 12% to 42 ± 9% and to 38 ± 3% 
in early and late injection, respectively (Suppl. Fig. S3). Since no significant difference was observed, further anal-
yses were conducted with early infection time.
Figure 2. Validation of CF embryos. (a,b) Impaired internal organ position in CF injected embryos. (a) The 
normal left-looping of the heart (ventral view of the embryo, visualized by means of cmlc2 in-situ hybridization 
techniques), and (b) the normal left-position of the liver (arrows, dorsal view of the embryo visualized by means 
of prox1a in-situ hybridization techniques), were impaired in CF injected embryos in comparison to controls. 
Scale bars indicate 100 μm. liv: liver; p: pancreas. (c) Induction of TNF-α and IL-β. Expression levels, measured 
by RT-qPCR analyses at 8 hpi, in 48 hpf WT and CF embryos injected with PAO1 (+PAO1) are given relative 
to the average levels measured in mock injected controls. One tailed t-test: t[4] = 7.62, p = 7.9E10−4 (TNF-α); 
t[4] = 15.26, p = 5.4E10−5 (IL-β). (d) PAO1 microcolony formation in the hindbrain ventricle of WT and CF 
zebrafish embryos. The amount of microcolonies in the CF background at 18 hpi was higher compared to 
the WT siblings injected with the same amount of PAO1 (100 cfu). Scale bar indicates 100 μm. hv: hindbrain 
ventricle.
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Phage therapy against PAO1 infection was applied to both WT and CF embryos; a significant reduction of 
lethality was observed (from 66 ± 6% to 35 ± 12% for the WT and from 83 ± 9% to 52 ± 7% for CF embryos 
Fig. 3a), indicating that phage therapy is effective in zebrafish both in a WT and in a CF background. We also 
Figure 3. Efficacy of phage therapy in zebrafish. (a) Lethality at 20 hpi in WT and CF zebrafish embryos 
infected with PAO1 (+PAO1) and treated with the phage cocktail (+PAO1 + φ). The mean and SD reported 
are from six and four experiments, respectively, each with 25–40 embryos. Angular transformation was applied 
to percentage of lethality and one-way ANOVA followed by Duncan’s test was used to test for significance. 
(WT + PAO1) vs (WT + PAO1 + φ) p = 0.004; (WT + PAO1) vs (CF + PAO1) p = 0.0003; (CF + PAO1) vs 
(CF + PAO1 + φ) p = 0.018. (b) Bacterial burden in WT or CF embryos infected with PAO1 or PAO1 + φ. 
The relative percentage of cfu/embryo in PAO1 + φ vs PAO1 embryos are given. The mean and SD of three 
independent experiments is reported. (c,d) Progression of the infection in WT (c) and CF (d) embryos 
following PAO1 injection (upper embryo) and efficacy of the phage therapy in PAO1 + φ injected embryos 
(bottom embryo) at 4, 9, 14 and 18 hpi. (e) Expression levels of the TNF-α and IL-β genes measured by RT-
qPCR at 8 hpi in WT (e) and CF (f) embryos injected at 48 hpf. The mean and SD of four experiments are 
reported. Statistical significance was assessed by ANOVA followed by Duncan’s test: (e) for TNF-α, (WT) vs 
(WT + PAO1) p = 0.0018; (WT) vs (WT + PAO1 + φ) p = 0.007; (WT + PAO1) vs (WT + PAO1 + φ) p = 0.22 
n.s.; for IL-β, (WT) vs (WT + PAO1) p = 0.0002; (WT) vs (WT + PAO1 + φ) p = 0.0001; (WT + PAO1) vs 
(WT + PAO1 + φ) p = 0.94 n.s.; (f) for TNF-α, (CF) vs (CF + PAO1) p = 0.015; (CF) vs (CF + PAO1 + φ) 
p = 0.019; (CF + PAO1) vs (CF + PAO1 + φ) p = 0.77 n.s.; for IL-β, (CF) vs (CF + PAO1) p = 0.00014; (CF) vs 
(CF + PAO1 + φ) p = 0.0007; (CF + PAO1) vs (CF + PAO1 + φ) p = 0.031. For simplicity sake, in the figures 
*p < 0.05; **p < 0.01, ***p < 0.001.
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determined the bacterial burden in WT and CF embryos at 8 hpi following phage administration: a reduction 
of average cfu/embryo to about 20% were observed after phage treatment (Fig. 3b). To follow the progression 
of PAO1 infection and the efficacy of phage therapy, we performed time laps analyses of WT and CF embryos 
injected with PAO1 and with PAO1 and the phages. As shown in Fig. 3c, in WT + PAO1 injected embryo (upper), 
the fluorescence increased at 14 hpi and 18 hpi, indicating that the GFP-positive bacteria multiply, whereas in the 
WT + PAO1 + φ embryo (bottom) the fluorescence did not increase, likely as an effect of the phage anti-bacterial 
activity. Same results in terms of phage therapy efficacy were obtained in the CF background but, as expected, the 
levels of bacterial infection in CF + PAO1 embryos was higher in comparison to WT + PAO1 embryos (Fig. 3d, 
and Videos S2 and S3). We also checked the pro-inflammatory response measuring the expression of TNF-α and 
IL-β cytokines by RT-qPCR (Fig. 3e,f). The pro-inflammatory immune response was activated in both WT and 
CF infections (WT + PAO1 and CF + PAO1) at 8 hpi; injection of the phage cocktail caused a slight reduction of 
cytokine expression that was significant only for IL-β in a CF background.
Analysis of phage effects on immune response. In the absence of PAO1 bacterial infection, to better 
understand if phages might induce per se an immune reaction, we measured the expression of TNF-α and IL-β 
in WT and CF embryos without (WT and CF) or after phage administration (WT + φ and CF + φ) at 20 hpi. 
Interestingly, we found that the expression of TNF-α and IL-β was significantly higher in CF embryos with respect 
to WT (Fig. 4). These data indicate that the reduced activity of Cftr, per se, determines a constitutive inflammatory 
state33–35. To our surprise, in CF + φ embryos, we observed reduced expression of both cytokines, suggesting that 
the phage cocktail may have a beneficial effect against the constitutive inflammation of CF embryos (Fig. 4). It is 
to note that an increased expression of IL-β, but not of TNF-α, was observed also in WT + φ embryos.
Combined effect of phages and antibiotics therapy. Since one of the main problems in CF patients 
is chronic bacterial infection and the development of antibiotic resistance, we tested the effects of combining 
phage therapy and antibiotic treatment by incubating CF + PAO1 embryos in fish water containing 100 μg/ml of 
ciprofloxacin (cipro), an antibiotic commonly used against P. aeruginosa infections. CF embryos infected with 
PAO1 and treated either with the antibiotic (PAO1 + cipro) or the phage cocktail (PAO1 + φ) showed reduced 
lethality in comparison to CF + PAO1 embryos. Interestingly, the combined treatment with phages and ciproflox-
acin (CF + PAO1 + φ + cipro) further reduced the lethality in comparison to embryos treated with either one of 
the two (Fig. 5).
Discussion
In this work, we demonstrated that phage therapy is able to fight P. aeruginosa infections in zebrafish embryos. 
Zebrafish embryos are gaining favour as infection models for pathogens like P. aeruginosa36,37. Recently, phage 
therapy has been applied to cure experimentally induced zebrafish infections by the fish pathogen Aeromonas 
hydrophila38. We recently showed that phage therapy cures acute respiratory P. aeruginosa infection in mouse 
and delays lethality in the wax moth G. mellonella larvae15. With this work, we enlarge the repertoire of infection 
models in which phage therapy against P. aeruginosa has been tested and proved to be effective, a relevant issue 
considering the wide variability of virulence shown by P. aeruginosa strains in different hosts39.
The usage of GFP-expressing bacteria coupled with transparency of zebrafish embryos allowed us to follow 
the bacterial infection in real time. Indeed, we observed that in the infected embryos that survive at 20 hpi, 
GFP-positive bacterial foci were present in different embryo districts indicating that the bacteria injected into 
the duct of Cuvier spread in the whole embryo and infect different organs. Furthermore, bacteria multiply in the 
Figure 4. TNF-α and IL-β expression in phage injected WT and CF embryos. Expression levels of the TNF-α 
and IL-β genes measured by RT-qPCR at 20 hpi in WT, WT + φ, CF and CF + φ embryos injected at 48 hpf. 
The mean and SD of four experiments are reported. Statistical significance was assessed by ANOVA followed 
by Duncan’s test: for TNF-α, (WT) vs (WT + φ) p = 0.96 n.s.; (WT) vs (CF) p = 0.022; (CF) vs (CF + φ) p = 0.23 
n.s. For IL-β, (WT) vs (WT + φ) p = 0.020; (WT) vs (CF) p = 0.00007; (CF) vs (CF + φ) p = 0.009.
www.nature.com/scientificreports/
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embryo as shown by time laps analyses of PAO1 injected embryos (see Fig. 3c,d and Videos S2 and S3) and initiate 
microcolonies formation, the precursors of biofilm.
In our experiments, a very low inoculum of bacteria (30 cfu/embryo) was lethal for zebrafish embryos. This 
result was different from previous observations done by Llamas and Van der Sar and colleagues36 that performed 
the same type of infection with a higher dose of bacteria (over 500 cfu/embryo). PAO1 bacterial strain used for 
the infection and the protocols were the same, therefore we hypothesise that the different response to the infec-
tion might be due to differences accumulated in the PAO1 strains, commonly used in different laboratories, as 
previously demostrated40.
We found that phage therapy is effective against P. aeruginosa infections also in a CF zebrafish model gener-
ated through the cftr-loss-of-function technique. To our knowledge, this is the first time that phage therapy is suc-
cessfully applied to an in vivo CF model system. To investigate the pathophysiology of CF several animal models 
have been developed including mouse, pig, and ferret41–43. Mouse models develop intestinal obstruction similar 
to CF patients, but fail to develop spontaneous lung disease44 and present only mild disease in the pancreas, 
likely due to compensatory calcium activated chloride channels45. The ferret and pig models of CF develop the 
pathophysiology characteristic of CF in many organs including lung and pancreas43, but they presented limited 
accessibility of developmental stages, high animal husbandry costs, and the impracticability of genetic analyses. 
Although devoid of lungs that are the main organs affected by P. aeruginosa infections in CF patients, zebrafish 
recently emerged as a powerful genetic model system to better understand CF onset and to develop new phar-
macological treatments21,26. Indeed, the genetically tractability of zebrafish embryos to precisely analyse gene 
function, their optically transparency which facilitates the visualization of development or infection progression 
in real time, make zebrafish a suitable CF model, and the lack of an adaptive immune response in embryos until 
30 days29, makes zebrafish an ideal model for studying innate immunity, which is the critical defence mechanism 
in human lung infections46,47. As already demonstrated, the CF background is more sensitive to P. aeruginosa 
PAO1 infections than the WT21. Indeed, we observed higher lethality and increased bacterial proliferation in 
CF + PAO1 embryos in comparison to WT + PAO1. In addition, after bacterial infection, CF embryos exhibit a 
delay in pro-inflammatory response in comparison to WT, suggesting an impairment of immune-response due 
to the absence of Cftr function.
Interestingly, we also observed that in the absence of induced PAO1 infection, in CF zebrafish embryos both 
TNF-α and IL-β cytokines were significantly activated in comparison to WT, suggesting that the lack of Cftr func-
tion, per se, causes a constitutive inflammatory state similar to the one present in human CF patients33–35. Indeed, 
previous studies using epithelial cells from CF patients have shown excessive expression of pro-inflammatory 
cytokines in absence of CFTR function47,48. We also demonstrated that in a CF background, the administra-
tion of the phage cocktail without bacterial infection, reduced TNF-α and IL-β expression to a level more sim-
ilar to WT embryos. It might be that phages, besides counteracting bacterial infections by killing bacteria, may 
Figure 5. Combination of phage therapy and ciprofloxacin treatment in CF embryos. 48 hpf embryos were 
injected with PAO1 (CF + PAO1), followed by injection of the phage cocktail (CF + PAO + φ) or incubation in 
fish water containing 100 μg/ml ciprofloxacin (CF + PAO + cipro) or both (CF + PAO + φ + cipro). Lethality 
was determined at 20 hpi. The mean and SD of three experiments is reported, each with 25–40 embryos/
treatment. Angular transformation was applied to percentage of lethality and one-way ANOVA followed by 
Dunnett’s test was used. p-values are reported for each treatment compared against CF + PAO1: CF + PAO + φ, 
p = 0.043; CF + PAO + Cipro, p = 0.014; CF + PAO + φ + Cipro, p = 0.005.
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display a secondary function, acting as immunomodulators. Indeed, the constitutive inflammatory state of CF 
embryos was reduced with phage injection, while in the WT sibling the phage injection determines an increase of 
cytokines expression. This suggests that phages, per se, might activate a mild immune response but, when a con-
stitutive inflammation is present as in the CF background, the final effect of phages is not pro-inflammatory. This 
hypothesis was raised previously by Gorsky and colleagues that reported that phages bind to mammalian cells, 
including lymphocytes, and produce immunosuppressive effects that enhance allogeneic skin allograft survival 
in mice49. Moreover, those effects were paralleled by phage-mediated inhibition of alloantigen-induced human T 
and B-cell responses in vitro, as well as specific antibody production in mice50. Thus, the potential of using phages 
as anti-inflammatory agents in CF patients might be evaluated.
In CF zebrafish embryos we observed positive interaction between phage and antibiotic therapy, as lethality 
was reduced when phage and ciprofloxacin were administered in combination to PAO1 infected embryos with 
respect to individual administrations. In other studies the combined action of phages and antibiotics has been 
proven to be helpful to control infections by different pathogens, including multiresistant strains51. Thus, the com-
bination of phage therapy and antibiotic administration appears as a promising therapeutic approach, especially 
in order to reduce antibiotic doses and treatment duration52.
Methods
Bacterial strain. P. aeruginosa PAO1-GFP (indicated as PAO1) strain was constructed in our lab by trans-
formation of PAO1 with a plasmid conferring carbenicillin resistance and expressing the GFP15. The strain can 
be observed by fluorescent microscopy. For the infection, PAO1 cultures were grown at 37 °C with shaking to 
OD600 = 0.5, corresponding to about 5 × 108 cfu/ml in LD broth53 added with carbenicillin (300 μg/ml), pelleted 
and resuspended in the same volume of physiological solution. Dilutions were used for microinjections in zebraf-
ish embryos.
Phage cocktail. Virulent phages that infect PAO1 used throughout this work were isolated and character-
ized previously15. Four phages were selected: two Podoviridae, GenBank accession numbers vB_PaeP_PYO2, 
MF490236, and vB_PaeP_DEV, MF490238, and two Myoviridae, vB_PaeM_E215, MF490241, and vB_PaeM_
E217, MF490240. Details of phages are reported in Suppl. Table S1. Each phage lysate was grown and purified 
as described by Forti et al.15; briefly, high-titer lysates of PAO1 cultures were filtrated with 1.2 μm diameter fil-
ters, incubated with DNase (1 μg/ml) and RNase (1 μg/ml), PEG precipitated, purified twice by cesium chlo-
ride ultracentrifugation, and dialyzed against TN buffer (10 mM Tris, 150 mM NaCl, pH 7), before endotoxin 
removal (EndoTrap HD, Hyglos, Germany) followed by measure of the endotoxin level by the LAL Chromogenic 
Endotoxin Quantitation (Pierce). The phage cocktail was assembled by mixing four phage preparations at the 
same pfu/ml immediately before each experiment to ensure accurate phage titres.
Zebrafish model. Zebrafish (Danio rerio) embryos were raised and maintained under standard condi-
tions in the fish facility of Cogentech s.c.a.r.l. (Aut. Prot. n. 007894 - 29/05/2018), via Adamello 16 - 20139 
Milan (Italy). According to international (EU Directive 2010/63/EU) and national guidelines (Italian decree 
4th March 2014, n. 26) on the protection of animals used for scientific purposes. Experiments with zebrafish are 
subject to regulations for animal experiments from 120 hpf onwards54. In this work we used exclusively zebraf-
ish embryos up to 120 hpf. Zebrafish AB strains obtained from the Wilson lab, University College London, 
London, United Kingdom were maintained at 28 °C on a 14 h light/10 h dark cycle. Embryos were collected by 
natural spawning, staged according to Kimmel et al.55 and raised at 28 °C in fish water (Instant Ocean, 0,1% 
Methylene Blue) in Petri dishes, according to established techniques. After 24 hpf, to prevent pigmentation 
0,003% 1-phenyl-2-thiourea (PTU, Sigma-Aldrich, Saint Louis, Missouri, USA) was added to the fish water. 
Embryos were washed, dechorionated and anaesthetized with 0.016% tricaine (Ethyl 3-aminobenzoate meth-
anesulfonate salt; Sigma-Aldrich), before observations and picture acquisitions. Antibiotic administration was 
performed by adding ciprofloxacin directly into the fish water at a concentration of 100 μg/ml immediately after 
the bacterial injection. For in situ hybridization analyses, embryos were fixed overnight in 4% paraformalde-
hyde (Sigma-Aldrich) in Phosphate Buffer Saline (PBS; Sigma-Aldrich) at 4 °C, then dehydrated stepwise to 
methanol and stored at −20 °C.
cftr-loss-of-function zebrafish embryos (CF embryos). Antisense oligonucleotide morpholino injec-
tions were carried out on 1- to 2-cell stage embryos; the dye tracer rhodamine dextran was also co-injected when 
necessary. To repress cftr mRNA translation, the cftr-ATG-MO and cftr-splice-MO (Gene Tools LLC, Philomath, 
OR) were used as previously described21. Morpholinos were injected in 1x Danieau buffer (pH 7, 6). As control 
(WT), we injected a standard control morpholino oligonucleotide that has no target in zebrafish (Gene Tools LLC).
Infection of zebrafish embryos with PAO1 and phages. PAO1 infection was performed in zebrafish 
embryos at 48 hpf by microinjecting 2 nl of bacterial suspension containing approximately 30 cfu/embryo into the 
duct of Cuvier, as previously described32. Evaluation of bacterial infection was performed following the guidelines 
of Takaki and colleagues56. To titre the injected bacteria, the same volume of the bacterial suspension was plated 
to determine the cfu; the titre of the injected bacteria was given by the average of eight independent measures. 
The phage cocktail (2 nl at 5 × 108 pfu/ml) was microinjected in the yolk after bacterial injection, and the phage 
titre calculated in the same way as done for bacteria. Different time of injection of the phage cocktail were tested: 
early (about 30 min) and late (7 h) with similar results. In most experiments, we used early injection for practical 
reasons. In each experiment 25–40 embryos were injected for any single treatment and each experiment was 
repeated at least three times.
Guidelines to visualize host-bacterial interaction were followed57: macrophages were visualized with the injec-
tion of the tol2(mpeg1:mCherry) construct at one-cell stage as described by Ellet and colleagues58.
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To visualise the microcolony formation, about 100 cfu of PAO1 were injected in the hindbrain ventricle of 
24 hpf zebrafish embryos as performed by Rocker and colleagues24. We considered microcolonies the bacterial 
aggregates with an area >5 μm2.
Determination of bacterial burden. PAO1 injected embryos were incubated at 28 °C for 8 hpi. 20 
embryos in 3 different experiments were mechanically homogenized by means of an insulin syringe and the 
resulting homogenate serially diluted and plated to calculate the bacterial titer. To limit the growth of other bac-
terial strains, present in the embryos, ampicillin (100 μg/ml) was added to the medium to select for the naturally 
amp-resistant PAO1 strain.
Determination of the expression level of pro-inflammatory cytokines genes. The expression 
level of TNF-α and IL-β genes were determined by reverse transcription-PCR and real-time quantitative-PCR 
(RT-qPCR) assays. Total RNA was extracted from zebrafish embryos at 8 hpi and 20 hpi using Trizol reagent 
(Life Technologies, Carlsbad, CA, USA) according to the producer’s instructions. After treatment with DNase 
I RNase-free (Roche Diagnostics, Basel, Swiss) to avoid possible genomic contamination, 1 μg of RNA was 
reverse-transcribed using the “ImProm-II™ Reverse Transcription System” (Promega, Madison, Wisconsin USA) 
and a mixture of oligo(dT) and random primers according to manufacturer’s instructions. qPCRs were carried 
out in a total volume of 20 µl containing 1X iQ SYBR Green Super Mix (Promega), using proper amount of the 
RT reaction. qPCRs were performed using the BioRad iCycler iQ Real Time Detection System (BioRad, Hercules, 
CA, USA). Thermocycling conditions were: 95 °C for 10 min, 95 °C for 10 s, and 55 °C for 30 s. All reactions were 
performed in triplicate for 40 cycles.
For normalization purposes, rpl8 expression levels were tested in parallel with the gene of interest. The follow-







In situ hybridization analyses. Whole mount in situ hybridization (WISH) experiments were carried 
out as described by Thisse and colleague59. Antisense riboprobes were previously in vitro labelled with digoxi-
genin (Roche Diagnostics). cmlc2 (myl7, Zebrafish Information Network) and prox1 probes have been previously 
described60. Images of embryos and sections were acquired using a microscope equipped with a digital camera 
with LAS Leica imaging software (Leica, Wetzlar, Germany). Images were processed using the Adobe Photoshop 
software and when necessary, different focal images planes of the same image were took separately and later 
merged in a single image.
Imaging. For live confocal imaging, embryos at 54 hpf were mounted in a glass-bottom Petri dish with 1,5% 
low-melting agarose in fish water with PTU and the anaesthetic Tricaine, and immediately imaged on an SP2 
confocal inverted microscope (Leica, Wetzlar, Germany) with an HC PL APO 10× objective and 488 nm argon 
laser for GFP and 587 nm for mcherry. Series of 300 μm z-stacks every 15 minutes were acquired. The frames 
resulted from confocal microscope acquisition were assembled and converted to an.avi movie using ImageJ soft-
ware. When necessary, images were cut and reassembled accordingly to the proper orientation and disposition of 
the embryos.
Statistical analyses. Angular transformation was applied to lethality data and transformed data analyzed 
by Student’s t or ANOVA, followed by post-hoc Duncan’s or Dunnett’s test, when required. The expression level 
of cytokines genes was analyzed by Student’s t or ANOVA. All analyses were run on STATISTICA v. 7.0 software.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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